G. Hudson
Long/short equity

Explanation Of Potential Damage Award In PharmAthene Versus Siga Lawsuit

I believe those people who have already analyzed the PharmAthene (NYSEMKT:PIP) vs. SIGA (NASDAQ:SIGA) legal case are trying to over complicate the Delaware Supreme Court's (NYSE:SC) May 24, 2013 opinion. Many people still believe the original equitable damages award granted by Judge Parsons is still an option since the Supreme Court seemed to be throwing out Judge Parsons' damage award only as it related to reversing promissory estoppel. The below excerpt starting at the bottom of page 37 and continuing on page 38 of the above Supreme Court opinion seemed to be interpreted by a lot of people as to the possibility of an equitable damage award still being an option for Judge Parsons....

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details